Weekly Canna Boss Babe Update: DEA Rescheduling Deadline Update
Reporting period: October 13–19, 2026
Another deadline in Washington, proposed rules in Nebraska, and a patient advisory in Maine: this week’s developments show why the details behind cannabis headlines matter.
Federal Updates: DEA Rescheduling Faces Another Deadline
October 21 response ordered; broader proceeding remains paused
Status: Procedural order—not a final rescheduling decision.
On October 14, DEA Chief Administrative Law Judge Derek C. Julius ordered the government to respond by October 21, 2026, to a motion seeking to reopen the marijuana rescheduling hearing for limited discovery and testimony.
The request relates to a Government Accountability Office report that opponents want added to the hearing record. The judge reserved a decision on admitting that report and confirmed that the proceeding remains stayed while the pending motions are considered.
What it means: October 21 is a deadline for a government response. It is not an effective date for broader rescheduling, and the order does not grant the request to reopen the hearing. The next meaningful developments are the response and the judge’s decisions on the outstanding motions.
State Regulations and Patient Safety
Nebraska’s proposed medical cannabis rules reach a public-comment milestone
Status: Proposed amendments—not final rules.
The Nebraska Medical Cannabis Commission scheduled an October 15 public hearing on proposed regulatory amendments, including an opportunity to comment on the proposed fee schedule. Written comments were due that night. The Commission’s notice explains that comments become part of the rulemaking record for its consideration.
What it means: A hearing and the close of a comment period do not make proposed rules effective. Applicants should follow subsequent Commission actions before treating draft requirements or fees as settled.
Maine issues advisory concerning The B Maine flower and pre-rolls
Status: Medical cannabis patient advisory.
On October 14, Maine’s Office of Cannabis Policy announced a patient advisory for cannabis flower and pre-rolls produced and sold by The B Maine.
What it means: Patients and businesses with potentially affected products should consult the agency’s advisory for its specific scope and instructions. The announcement should not be described as a statewide warning covering all Maine cannabis.
U.S. Cannabis Industry News
Colorado reports $19.3 million in monthly cannabis taxes and fees
Status: Government revenue report—not a new tax increase.
Colorado’s October 15 release reports $19,322,443 in marijuana tax and fee revenue for August 2026, up from approximately $19 million in July. The same release reports $111.2 million in July cannabis sales, compared with approximately $105.6 million in June.
What it means: The sales and revenue figures cover different months. They document economic activity and public revenue, but do not establish whether individual operators are profitable.
Global Cannabis & Industry Watch
Aurora’s board continues opposing Curaleaf’s takeover bid
Status: Contested acquisition proposal—not a completed merger.
In an October 14 company announcement, Canadian medical cannabis company Aurora reaffirmed its board’s recommendation that shareholders reject Curaleaf’s revised hostile takeover offer. Aurora said its special committee continues exploring alternatives, including potential transactions or remaining independent. Those statements represent Aurora’s position in an ongoing corporate dispute.
What it means: The proposed combination remains contested. Businesses following international cannabis consolidation should distinguish company announcements and shareholder recommendations from completed transactions.
Advocacy Points
Ask what a deadline actually changes. A filing deadline is different from a final decision or effective date.
Follow rulemaking beyond the hearing. Fees and operating requirements matter when they become final.
Share patient advisories precisely. Identify the named products and direct readers to the regulator’s instructions.
Put public revenue beside business realities. Tax collections alone do not show whether small businesses can survive.
This article is for educational and advocacy purposes only and is not legal advice. Cannabis and hemp laws change quickly. Verify current requirements with the appropriate government agency or qualified legal counsel before making compliance or business decisions.
Comments